Article
Distinct Adverse Event Profiles of Eight Chemotherapeutic Agents: A FAERS Database Analysis Focusing on Peripheral Neuropathy
2025-12-10
Abstract excerpt
<h4>Background: </h4> Chemotherapy-induced peripheral neuropathy (CIPN) is a common dose-limiting toxicity of many anticancer agents, impairing patients’ quality of life and treatment continuity. The FDA Adverse Event Reporting System (FAERS) supports post-marketing drug safety surveillance. This study aimed to identify CIPN-related adverse event signals for 8 chemotherapeutics (oxaliplatin, sunitinib, paclitaxel,...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 24650af2-f05e-5e16-a2ce-31994f452153
- DOI
- 10.22541/au.176533943.33305815/v1
